Skip links

News

researchers-identify-novel-biomarker-linked-to-cancer-aggressiveness

Researchers Identify Novel Biomarker Linked to Cancer Aggressiveness

In a groundbreaking study recently published in the esteemed journal Science, researchers affiliated with Fred Hutch Cancer Center and The University of Texas MD Anderson Cancer Center have identified a novel biomarker that has the potential to revolutionize the diagnosis and treatment of certain cancer
rptu-researchers-uncover-molecular-mechanisms-behind-cancer-cell-behavior

RPTU Researchers Uncover Molecular Mechanisms Behind Cancer Cell Behavior

Researchers at RPTU University Kaiserslautern-Landau have made significant strides in understanding how cancer cells adapt to genetic irregularities. Their recent study focuses on aneuploidy, a condition where cells possess an abnormal number of chromosomes, which is prevalent in around 90 percent of tumors. This phenomenon
discoveries-from-msk-research:-highlights-and-innovations-–-february-13,-2025

Discoveries from MSK Research: Highlights and Innovations – February 13, 2025

New advances in cancer research are propelling the field toward breakthroughs that may change the landscape of treatment for various malignancies. Memorial Sloan Kettering Cancer Center (MSK) has been at the forefront of several pivotal studies that highlight innovative approaches to combatting cancer. Specifically, recent
guardian-molecule:-a-new-target-for-advancing-liver-cancer-treatments

Guardian Molecule: A New Target for Advancing Liver Cancer Treatments

A breakthrough discovery by researchers from the German Cancer Research Center (DKFZ), the Hector Institute for Translational Brain Research (HITBR), and the European Molecular Biology Laboratory (EMBL) highlights the pivotal role of a guardian molecule known as PROX1 in maintaining the identity of liver cells.
breakthrough-blood-test-detects-challenging-pancreatic-cancer-with-85%-accuracy

Breakthrough Blood Test Detects Challenging Pancreatic Cancer with 85% Accuracy

A groundbreaking leap in the field of oncology emerges from Oregon Health & Science University (OHSU), where researchers have unveiled a revolutionary blood test called PAC-MANN. This novel test represents a significant advancement in the early detection of pancreatic cancer, particularly pancreatic ductal adenocarcinoma (PDAC),
Explore
Drag